Belgija - engleski - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bayer sa-nv - magnesium carbonate 194,82 mg; thiamine nitrate 14,57 mg; riboflavin 15 mg; pyridoxine hydrochloride 10 mg; nicotinamide 50 mg; calcium pantothenate 25 mg - eq. pantothenic acid 23 mg; cyanocobalamin 0,01 mg; folic acid 0,4 mg; calcium carbonate 244 mg - eq. calcium 100 mg; zinc citrate 32,05 mg - eq. zinc 10 mg; ascorbic acid 500 mg; biotin 0,15 mg; magnesium oxide 115 mg - film-coated tablet - cyanocobalamin 0.01 mg; folic acid 0.4 mg; magnesium oxide 115 mg; magnesium carbonate 194.82 mg; nicotinamide 50 mg; riboflavin 15 mg; pyridoxine hydrochloride 10 mg; pantothenate calcium 25 mg; thiamine nitrate 14.57 mg; calcium carbonate 244 mg; biotin 0.15 mg; ascorbic acid 500 mg; zinc citrate 32.05 mg - vitamin b-complex with minerals; a11eb vitamin b-complex with vitamin c

Saudijska Arabija - engleski - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

roche - nicotinamide, pyridoxine, riboflavin, thiamine - tablet

Saudijska Arabija - engleski - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

roche - nicotinamide, pyridoxine, riboflavin, thiamine - syrup

Jordan - engleski - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة مستودع الأدوية الأردني - the jordan drugstore co - nicotinamide 50 mg, calcium pantothenate 25 mg, biotin 0.15 mg, vitamin b12 0.01 mg, pyridoxine hcl 10 mg, riboflavin 15 mg, thiamine mononitrate 15 mg - 50 mg, 25 mg, 0.15 mg, 0.01 mg, 10 mg, 15 mg, 15 mg

Ujedinjeni Arapski Emirati - engleski - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

alphamed drug store germany - 20's [2x10's blister] - tablet - combination - nutrition , blood-vitamins

Belgija - engleski - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bayer sa-nv - magnesium carbonate 194,82 mg; pyridoxine hydrochloride 10 mg; nicotinamide 50 mg; calcium pantothenate 25 mg - eq. pantothenic acid 23 mg; cyanocobalamin 0,01 mg; folic acid 0,4 mg; calcium carbonate 243,98 mg - eq. calcium 100 mg; zinc citrate 32,04 mg - eq. zinc 10 mg; thiamine hydrochloride 15 mg; riboflavin sodium phosphate 20,51 mg - eq. riboflavin 15 mg; ascorbic acid 500 mg; magnesium sulfate dihydrate 328,2 mg; biotin 0,15 mg - effervescent tablet - vitamin b-complex with minerals; a11eb vitamin b-complex with vitamin c

Belgija - engleski - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bayer sa-nv - magnesium carbonate 194,82 mg; pyridoxine hydrochloride 10 mg; nicotinamide 50 mg; calcium pantothenate 25 mg - eq. pantothenic acid 23 mg; cyanocobalamin 0,01 mg; folic acid 0,4 mg; calcium carbonate 243,98 mg - eq. calcium 100 mg; zinc citrate 32,04 mg - eq. zinc 10 mg; thiamine hydrochloride 15 mg; riboflavin sodium phosphate 20,51 mg - eq. riboflavin 15 mg; ascorbic acid 500 mg; magnesium sulfate dihydrate 328,2 mg; biotin 0,15 mg - effervescent tablet - vitamin b-complex with minerals; a11eb vitamin b-complex with vitamin c

Australija - engleski - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - furosemide, quantity: 10 mg/ml - oral liquid, solution - excipient ingredients: glycerol; purified water; sodium hydroxide; sorbitol solution (70 per cent) (non-crystallising); methyl hydroxybenzoate; ethanol; propyl hydroxybenzoate; sunset yellow fcf; quinoline yellow; flavour - oedema: lasix is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease, including the nephrotic syndrome. lasix is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired. parenteral therapy should be reserved for patients unable to take oral medication or for patients in emergency clinical situations. lasix injection is also indicated as adjunctive therapy in acute pulmonary oedema and cerebral oedema where intense and rapid onset of diuresis is desired. if gastrointestinal absorption is impaired or oral medication is not practical for any reason, lasix is indicated by the intravenous route. parenteral use should be replaced with oral lasix as soon as practical.hypertension. oral lasix may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents. hypertensive patients who cannot be adequately controlled with thiazides will probably also not be adequately controlled with lasix alone.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - fluconazole, quantity: 10 mg/ml - oral liquid, powder for - excipient ingredients: sucrose; citric acid; sodium citrate dihydrate; sodium benzoate; xanthan gum; colloidal anhydrous silica; titanium dioxide; flavour - indications as at 21 may 2004 : diflucan, given orally, is indicated for: 1. treatment of cryptococcal meningitis in patients who are unable to tolerate amphotericin b. note : data suggest that the clinical efficacy of diflucan is lower than that of amphotericin b in the treatment of the acute phase of cryptococcal meningitis. 2. maintenance therapy to prevent relapse of cryptococcal meningitis in patients with aids. 3. treatment of oropharyngeal and oesophageal candidiasis in aids and other immunosuppressed patients. 4. secondary prophylaxis of oropharyngeal candidiasis in patients with hiv infection. 5. serious and life-threatening candida infections in patients who are unable to tolerate amphotericin b. note : it remains to be shown that diflucan is as effective as amphotericin b in the treatment of serious and life-threatening candida infections. until such data are available, amphotericin b remains the drug of choice. 6. vaginal candidiasis when topical therapy has failed. 7. treatment of extensive tinea corporis, extensive tinea cruris and extensive tinea pedis infections in immunocompetent patients in whom topical therapy is not a practical treatment option. usually, topical therapy should be attempted first because oral therapy has a less favourable ratio of benefits to risks (see adverse reactions). diflucan iv is indicated for the same conditions in adults and children but should be used only when diflucan cannot be administered orally.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - phenytoin, quantity: 6 mg/ml - oral liquid, suspension - excipient ingredients: sodium benzoate; polysorbate 40; citric acid monohydrate; glycerol; purified water; carmellose sodium; ethanol; vanillin; carmoisine; sucrose; sunset yellow fcf; aluminium magnesium silicate; flavour - dilantin is indicated for the control of grand mal and psychomotor seizures. dilantin will prevent or effectively decrease the incidence and severity of convulsive seizures in a high percentage of cases, with patients exhibiting little tendency to become resistant to its action. besides its effectiveness in controlling seizures, dilantin frequently improves the mental condition and outlook of epileptic patients and there is also increasing evidence that dilantin is valuable in the prevention of seizures occurring during or after neurosurgery and in the treatment of certain cardiac arrythmias. phenytoin serum level determinations may be necessary for optimal dosage adjustments (see dosage and administration).